Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  CD19CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Genetically Engineered Donor T Cells in Treating Patients With Relapsed Acute Lymphocytic Leukemia After Donor Stem Cell Transplant
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 01410, NCI-2014-00235, 811344, NCT01551043
Start Over